Asset Strategy: Growth Equity
PulmOne Advanced Medical Devices, Ltd. (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in PulmOne. PulmOne’s MiniBox+ performs pulmonary function testing (PFT) that is less expensive, easy to use, portable, and compact. This allows the company to compete in the current body box market and expand beyond that market into areas not currently served by body box devices including smaller pulmonology clinics,
Anodot Ltd.
Through OurCrowd’s investment platform, Dancap invested in Anodot, a business data analytics platform that utilizes patented automated machine learning algorithms that in real time monitor, alert and suggest solutions for anomalies within a company’s data stream before potential problems impact customers or revenues. This enables clients to reduce detection time and consequently safeguards revenue, minimizes
PROOF Fund III (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in The Pro Rata Opportunity Fund (PROOF), a US-based fund providing investors with access to top venture-backed companies. PROOF invests in the unfilled pro-rata rights of small-cap VCs that no longer have the capital to follow on in the subsequent financing rounds of their best investments. As part of
U.S. Venture Partners Fund XIII
Through OurCrowd’s investment platform, Dancap invested in U.S. Venture Partners Fund XIII, a fund of a leading Silicon Valley venture capital firm based in Menlo Park, California. The fund’s team, with their established track record of consistent returns, will focus its investment activity where it sees the greatest opportunity and has the greatest expertise: the
SaNOtize Research and Development Corp. (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in SaNOtize, a life science therapeutics company that has developed a patented formulation that allows a safe, dose-controlled delivery of nitric oxide gas to the site of infection without gas cylinders. The technology shows efficacy for prevention and treatment of influenza and Covid-19. With antibiotic resistance increasing throughout the
Re-Milk Ltd. (OurCrowd)
Remilk uses a technique known as precision fermentation from a recombinant source (DNA molecules formed by laboratory methods of genetic recombination to bring together genetic material from multiple sources) in order to synthetically produce casein micelles in powder form. Remilk’s target customers are dairy food processors, who will then add water, oils, and vegetable sugars
Eko Devices Inc. (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in Eko Devices Inc. Eko develops cardiac screening devices, care coordination software, and interpretive algorithms to enable better monitoring and management of cardiovascular diseases. Eko’s algorithms have a >85% accuracy as compared to 20-50% for alternative methods, resulting in faster diagnosis, optimal treatments, and superior outcomes.
Foretellix Ltd. (OurCrowd)
Foretellix is enabling the digital transformation of safety-critical automotive verification. Foretellix’s solutions uniquely scale to meet the challenge of verifying the safety of today’s increasingly complex automated driving systems. The platform orchestrates and manages the massive scale of testing required to ensure safety, reduce development costs, and shorten the time to market of Automated Driving
Innovalve Bio Medical Ltd. (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in Innovalve, a biomedical startup that is developing a Transcatheter Mitral Valve Replacement solution. Today, the only means of replacing a diseased mitral valve is by highly-invasive open-heart surgery. The device hopes to enable a simple, fast and safe catheter-based mitral valve replacement, yielding better clinical outcomes for a
Hailo (OurCrowd)
Through OurCrowd’s investment platform, Dancap invested in Hailo’s technology, which has developed an optimized processor for deep learning workloads, which it believes delivers unprecedented performance to edge devices. Hailo reports that its chip is built with an innovative architecture that enables edge devices to run sophisticated deep learning applications faster, while consuming less energy and